Literature DB >> 2589840

Purification and characterization of an antibacterial substance produced by a marine Alteromonas species.

J L Barja1, M L Lemos, A E Toranzo.   

Abstract

An extracellular inhibitory substance produced by the marine Alteromonas strain P-31 (NCMB 2144) was isolated and purified. The inhibitor was a macromolecule with a molecular weight of 90,000 estimated by Sephadex G-100 chromatography and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The inhibitory activity was antagonized by proteinase K and beta-amylase and inactivated by heating at 80 degrees C for 30 min. The purified substance exhibited two typical absorption bands in the infrared spectrum at 1,650 and 1,075 cm-1, corresponding to peptide linkages and carbohydrate residues, respectively. These findings allowed us to characterize the antimicrobial compound as a thermolabile glycoprotein. The substance exhibited a broad inhibitory spectrum, being active against clinical and environmental isolates from related and nonrelated taxonomical bacterial groups as well as against the producer strain and other similar marine bacterial strains. The inhibitory glycoprotein did not display cytotoxicity toward mammalian and fish cell lines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589840      PMCID: PMC172736          DOI: 10.1128/AAC.33.10.1674

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  [On microbiology in Cairo].

Authors:  A A IMSHENETSKII
Journal:  Mikrobiologiia       Date:  1961 May-Jun

2.  Antibiotic Production by Marine Microorganisms.

Authors:  W D Rosenfeld; C E Zobell
Journal:  J Bacteriol       Date:  1947-09       Impact factor: 3.490

3.  Modification of bacterial respiration by a macromolecular polyanionic antibiotic produced by a marine Alteromonas.

Authors:  M J Gauthier
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

4.  New anti-Pseudomonas agent isolated from a marine vibrio.

Authors:  R G Doggett
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Antiviral activity of antibiotic-producing marine bacteria.

Authors:  A E Toranzo; J L Barja; F M Hetrick
Journal:  Can J Microbiol       Date:  1982-02       Impact factor: 2.419

7.  Antibiotic metabolites from a marine pseudomonad.

Authors:  S J Wratten; M S Wolfe; R J Andersen; D J Faulkner
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

8.  Antibacterial activity of marine violet-pigmented Alteromonas with special reference to the production of brominated compounds.

Authors:  M J Gauthier; G N Flatau
Journal:  Can J Microbiol       Date:  1976-11       Impact factor: 2.419

9.  Inhibitory activity of antibiotic-producing marine bacteria against fish pathogens.

Authors:  C P Dopazo; M L Lemos; C Lodeiros; J Bolinches; J L Barja; A E Toranzo
Journal:  J Appl Bacteriol       Date:  1988-08

10.  Estimation of the molecular weights of proteins by Sephadex gel-filtration.

Authors:  P Andrews
Journal:  Biochem J       Date:  1964-05       Impact factor: 3.766

View more
  9 in total

1.  Isolation of a potent antibiotic producer bacterium, especially against MRSA, from northern region of the Persian Gulf.

Authors:  Esmaeil Darabpour; Mohammad Roayaei Ardakani; Hossein Motamedi; Mohammad Taghi Ronagh
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

2.  Competitive interactions in mixed-species biofilms containing the marine bacterium Pseudoalteromonas tunicata.

Authors:  Dhana Rao; Jeremy S Webb; Staffan Kjelleberg
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

3.  Bacteriostatic anti-Vibrio parahaemolyticus activity of Pseudoalteromonas sp. strains DIT09, DIT44 and DIT46 isolated from Southern Chilean intertidal Perumytilus purpuratus.

Authors:  Carlos P Aranda; Cristian Valenzuela; Javier Barrientos; Javier Paredes; Pablo Leal; Miguel Maldonado; Félix A Godoy; Carlos G Osorio
Journal:  World J Microbiol Biotechnol       Date:  2012-03-30       Impact factor: 3.312

4.  Purification and partial identification of novel antimicrobial protein from marine bacterium Pseudoalteromonas species strain X153.

Authors:  Arlette Longeon; Jean Peduzzi; Michel Barthélemy; Sophie Corre; Jean-Louis Nicolas; Michéle Guyot
Journal:  Mar Biotechnol (NY)       Date:  2004 Nov-Dec       Impact factor: 3.619

5.  Antibacterial activity of marine culturable bacteria collected from a global sampling of ocean surface waters and surface swabs of marine organisms.

Authors:  Lone Gram; Jette Melchiorsen; Jesper Bartholin Bruhn
Journal:  Mar Biotechnol (NY)       Date:  2009-10-13       Impact factor: 3.619

Review 6.  Spotlight on Antimicrobial Metabolites from the Marine Bacteria Pseudoalteromonas: Chemodiversity and Ecological Significance.

Authors:  Clément Offret; Florie Desriac; Patrick Le Chevalier; Jérôme Mounier; Camille Jégou; Yannick Fleury
Journal:  Mar Drugs       Date:  2016-07-08       Impact factor: 5.118

7.  Genomic analyses of two Alteromonas stellipolaris strains reveal traits with potential biotechnological applications.

Authors:  Marta Torres; Kar-Wai Hong; Teik-Min Chong; José Carlos Reina; Kok-Gan Chan; Yves Dessaux; Inmaculada Llamas
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

8.  Bioactive compound synthetic capacity and ecological significance of marine bacterial genus pseudoalteromonas.

Authors:  John P Bowman
Journal:  Mar Drugs       Date:  2007-12-18       Impact factor: 5.118

9.  Antioxidant and antimicrobial potential of the Bifurcaria bifurcata epiphytic bacteria.

Authors:  André Horta; Susete Pinteus; Celso Alves; Nádia Fino; Joana Silva; Sara Fernandez; Américo Rodrigues; Rui Pedrosa
Journal:  Mar Drugs       Date:  2014-03-24       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.